Tuesday 29 September 2015 7:23 am Roche breast cancer drug wins approval for use in UK By: Sarah Spickernell Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on LinkedIn WhatsApp Share on WhatsApp Email Share on Email NULL News Updates Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.
Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocarcinoma1
Marsh McLennan’s Mercer to Invest in a Bespoke Long-Term Asset Fund for Private Markets With an Initial Commitment of £350 Million